Every year, hundreds of promising basic discoveries in the pharmacological field are lost and will never have a chance to be exploited for patients due to difficulties in clinical translation. This is especially true for most neurodegenerative disorders lacking disease-modifying therapies. Here we present the current scenario and our vision of a 'collective-impact' multistakeholder approach to expedite the development of new drugs.
Zaratin, P., Battaglia, M.A., Abbracchio, M.P. (2014). Nonprofit foundations spur translational research. TRENDS IN PHARMACOLOGICAL SCIENCES, 35(11), 552-555 [10.1016/j.tips.2014.09.003].
Nonprofit foundations spur translational research
BATTAGLIA, MARIO ALBERTO;
2014-01-01
Abstract
Every year, hundreds of promising basic discoveries in the pharmacological field are lost and will never have a chance to be exploited for patients due to difficulties in clinical translation. This is especially true for most neurodegenerative disorders lacking disease-modifying therapies. Here we present the current scenario and our vision of a 'collective-impact' multistakeholder approach to expedite the development of new drugs.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Zaratin TIPS 2014.pdf
non disponibili
Tipologia:
PDF editoriale
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
281.53 kB
Formato
Adobe PDF
|
281.53 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/986215
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo